Clinical Trials › NCT06141486
RecruitingPhase 3
Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis
Sponsored by Sanofi
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 900
Target enrollment
38
U.S. states
Dec 2023
Start date
Mar 2028
Expected completion
Interventions / Treatments
FrexalimabPlaceboMRI contrast-enhancing agents
Conditions studied
Multiple Sclerosis
Where this trial is running (103 sites)
Florida12 sites
Altamonte Springs · Boca Raton · Clearwater · +9 more
California9 sites
Berkeley · Carlsbad · Irvine · +6 more
Massachusetts5 sites
Boston · Boston · Foxborough · +2 more
Michigan5 sites
Detroit · Farmington Hills · Grand Rapids · +2 more
Ohio5 sites
Cincinnati · Cincinnati · Columbus · +2 more
Arizona4 sites
Phoenix · Scottsdale · Scottsdale · +1 more
Illinois4 sites
Chicago · Chicago · Northbrook · +1 more
New York4 sites
Amherst · New York · New York · +1 more
Texas4 sites
Dallas · Plano · San Antonio · +1 more
Virginia4 sites
Fairfax · Newport News · Vienna · +1 more
Connecticut3 sites
New Haven · Norwich · Stamford
Louisiana3 sites
Alexandria · Baton Rouge · New Orleans
Maryland3 sites
Baltimore · Baltimore · Lutherville
Minnesota3 sites
Minneapolis · Minneapolis · Plymouth
North Carolina3 sites
Charlotte · Raleigh · Winston-Salem
Colorado2 sites
Aurora · Fort Collins
Georgia2 sites
Savannah · Smyrna
Kansas2 sites
Kansas City · Overland Park
Missouri2 sites
Ozark · St Louis
Nevada2 sites
Las Vegas · Reno
New Jersey2 sites
New Brunswick · Teaneck
Pennsylvania2 sites
Hershey · Philadelphia
Tennessee2 sites
Knoxville · Nashville
Wisconsin2 sites
Milwaukee · Milwaukee
Alabama1 site
Birmingham
District of Columbia1 site
Washington D.C.
Indiana1 site
Merrillville
Iowa1 site
Iowa City
Kentucky1 site
Lexington
New Hampshire1 site
Lebanon
New Mexico1 site
Albuquerque
North Dakota1 site
Fargo
Oklahoma1 site
Oklahoma City
Oregon1 site
Portland
South Carolina1 site
Greenville
Vermont1 site
Burlington
Washington1 site
Seattle
West Virginia1 site
Morgantown
Participating MS centers on MS Buddy (68)
Neurology Consultants of Dallas
Dallas, TX
Dallas, TX
International Neurorehabilitation Institute
Lutherville, MD
Lutherville, MD
The Elliot Lewis Center for Multiple Sclerosis Care
Wellesley, MA
Wellesley, MA
Mayo Clinic Florida MS Program
Jacksonville, FL
Jacksonville, FL
UC San Diego Health MS Program
La Jolla, CA
La Jolla, CA
UCI Health Multiple Sclerosis Program
Orange, CA
Orange, CA
Michigan Institute For Neurological Disorders MIND
Farmington Hills, MI
Farmington Hills, MI
Tufts Medicine MS Program
Boston, MA
Boston, MA
University of Maryland Center for Multiple Sclerosis
Baltimore, MD
Baltimore, MD
Charlotte Center for Multiple Sclerosis
Charlotte, NC
Charlotte, NC
Swedish Neuroscience Institute MS Center
Seattle, WA
Seattle, WA
Robert Wood Johnson Center for MS
New Brunswick, NJ
New Brunswick, NJ
John L. Trotter Multiple Sclerosis Center
Saint Louis, MO
Saint Louis, MO
Savannah Neurology Specialists
Savannah, GA
Savannah, GA
Lone Star Neurology of San Antonio
San Antonio, TX
San Antonio, TX
University of Minnesota Multiple Sclerosis Center
Minneapolis, MN
Minneapolis, MN
OMRF Multiple Sclerosis Center of Excellence
Oklahoma City, OK
Oklahoma City, OK
Neurology of Central Florida
Altamonte Springs, FL
Altamonte Springs, FL
USC Multiple Sclerosis Comprehensive Care Center
Los Angeles, CA
Los Angeles, CA
The Minnesota Center for MS
Plymouth, MN
Plymouth, MN
Neurology Center of New England, P.C.
Foxboro, MA
Foxboro, MA
INOVA MS and Neuro-Immunology Center
Falls Church, VA
Falls Church, VA
Dent Neurologic Institute MS Program
Amherst, NY
Amherst, NY
Advanced Neurology of Colorado
Fort Collins, CO
Fort Collins, CO
Mercy Health Saint Mary's Multiple Sclerosis Center
Grand Rapids, MI
Grand Rapids, MI
Johns Hopkins Multiple Sclerosis Center
Baltimore, MD
Baltimore, MD
Columbia University Multiple Sclerosis Center
New York, NY
New York, NY
Sentara Neuroscience Institute
Norfolk, VA
Norfolk, VA
Methodist Hospitals Neuroscience Institute
Merrillville, IN
Merrillville, IN
Tanner Center for Multiple Sclerosis
Birmingham, AL
Birmingham, AL
Cedars-Sinai Multiple Sclerosis Clinic
Los Angeles, CA
Los Angeles, CA
Hope Neurology, PLLC
Knoxville, TN
Knoxville, TN
USF Multiple Sclerosis Center
Tampa, FL
Tampa, FL
The University of Iowa Hospitals and Clinics
Iowa City, IA
Iowa City, IA
Baptist Health Lexington Neurology
Lexington, KY
Lexington, KY
The Waddell Center for Multiple Sclerosis
Cincinnati, OH
Cincinnati, OH
OhioHealth Multiple Sclerosis Center
Columbus, OH
Columbus, OH
Thomas Jefferson University Comprehensive MS Center
Philadelphia, PA
Philadelphia, PA
Stanford MS & Neuroimmunology Clinic
Palo Alto, CA
Palo Alto, CA
Riverside Hampton Roads Neurology MS Center
Newport News, VA
Newport News, VA
University of Chicago MS Clinic
Chicago, IL
Chicago, IL
Kansas City Multiple Sclerosis Center, College Park Neurology
Overland Park, KS
Overland Park, KS
Georgetown Multiple Sclerosis and Neuroimmunology Center
Washington, DC
Washington, DC
Springfield Clinic Neurology
Springfield, IL
Springfield, IL
UMass Memorial Medical Center MS Clinic
Worcester, MA
Worcester, MA
Premier Neurology, PC
Greenville, SC
Greenville, SC
Providence Multiple Sclerosis Center
Portland, OR
Portland, OR
Wake Forest Baptist Health MS Center
Winston-Salem, NC
Winston-Salem, NC
Sanford NeuroScience
Fargo, ND
Fargo, ND
Texas Institute for Neurological Disorders
Sherman, TX
Sherman, TX
MS centers in Florida
Compare treatment centers near a trial site — patient experience, providers, and care ratings.
View Florida centersMore Phase 3 trials
Browse all Phase 3 MS trialsCheck out the MS Buddy App
Track symptoms, monitor wellness, and stay on top of your MS care. It's free, no ads. How? It's made and supported by MS patients who get their ideas from other MS patients.
